Nanjing Nanda Pharmaceutical

Nanjing Nanda Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development and production of biochemical drugs, particularly in the fields of thrombolysis and anticoagulation. Established in 1988 and originally affiliated with Nanjing University, the company has grown into a major global supplier of Urokinase and Heparin-based products. Its core portfolio includes Urokinase for injection, Heparin Sodium, and Low Molecular Weight Heparin Calcium, which are used to treat cardiovascular and cerebrovascular conditions such as myocardial infarction and pulmonary embolism. The company maintains high-standard GMP manufacturing facilities and exports its active pharmaceutical ingredients (APIs) to numerous international markets. Nanjing Nanda Pharmaceutical continues to leverage its academic roots to advance biochemical extraction and purification technologies.